Amy Niles

Patient Advocate Foundation's Amy Niles on faster CMS prior authorization rules, Medicaid work requirements and what shrinking coverage means for patients.

Four pharma experts discuss industry trends in M&A, direct-to-patient sales, patient access and commercial strategy at the H1 midyear mark.

Four pharma commerce experts revisit their 2026 predictions on dealmaking, patient access and commercialization at the year's midpoint.

Four pharma commerce voices check back in at the midpoint of 2026 to see how their dealmaking, patient access and commercialization predictions have held up.

Amy Niles of the Patient Advocate Foundation on the Medicare Part D cap, Medicaid, ACA exchanges and rural hospital access in late 2026.

Amy Niles of the Patient Advocate Foundation on Medicaid work requirements, ACA subsidy expiration and patient affordability in 2026.

Amy Niles of the Patient Advocate Foundation revisits her 2026 outlook on prior authorization reform and the Medicare Prescription Payment Plan.

Policy shifts bring meaningful improvements for some—but looming coverage losses and rising premiums threaten to erase those gains.

Rising prescription costs and premiums are forcing more than half of patients to take drastic measures to cover OOP costs.

Marketed as cost-saving tools, AFPs can also strain safety-net resources.

Why it’s time to act on passing key bills to boost access for millions.

Many uninsured and underinsured individuals remain unaware of vital financial assistance programs for prescription costs, highlighting a critical need for increased awareness and resources.

A look at the prevailing factors impacting treatment access in 2025.

New engagement approaches can help drive treatment gains in underrepresented communities.

While the program could be a good option for many, it's not a panacea.

Why looming benefit changes—and the resulting unintended consequences—are a concern for patients.

Will the looming changes address the concerns of the patient assistance community?

If Congress doesn't act soon, it could result in more health inequities.

Patients should not have to wait to access the medication they need.

And the need to boost awareness of this critical healthcare resource.